Article
Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
Neuro-oncology - 1 Aug 2017
Yesilöz Ümmügülsüm, Kirches Elmar, Hartmann Christian, Scholz Johannes, Kropf Siegfried, Sahm Felix, Nakamura Makoto, Mawrin Christian
Abstract excerpt
BACKGROUND: Skull base meningiomas are considered to be difficult for surgical treatment. We wondered whether genetic alterations recently identified in benign non-NF2-mutated World Health Organization (WHO) grade I meningiomas are related to clinical features of skull base meningiomas and whether druggable signaling pathways are activated. METHODS: We analyzed 93 skull base meningiomas (82 WHO grade I, 11 WHO...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
